Press Releases

AdvaMed Statements on Nomination of Dr. Robert Califf to Lead FDA

WASHINGTON, D.C. – AdvaMed, the world’s largest trade organization representing medical technology companies, released the following statements on President Joe Biden’s nomination of Dr. Robert Califf to serve again as Commissioner of the Food and Drug Administration: 

AdvaMed President and CEO Scott Whitaker:“On behalf of the medtech industry, I congratulate Dr. Califf on his nomination to again lead FDA. His prior experience as FDA Commissioner will be invaluable as he oversees the global gold standard for medical device safety and effectiveness. If confirmed by the Senate, Dr. Califf will be tasked with protecting and promoting the public health, as well as the crucial role of innovation in improving patient care, and we look forward to working closely with him to meet these goals on behalf of the patients we serve. We also want to thank Dr. Janet Woodcock for her steadfast leadership as acting commissioner during this historic pandemic.”

Abiomed Chairman, President, and CEO Mike Minogue, Chairman of the AdvaMed Board of Directors: “I welcome the nomination of Commissioner Califf to serve again as FDA Commissioner. I have enjoyed working with him over the years, and I look forward to working together again to strengthen our public-private partnership with FDA, as the agency and our companies work toward our common goal of bringing safe, effective medical technologies into the hands of patients and their doctors.”

# # #

AdvaMed member companies produce the medical devices, diagnostic products and digital health technologies that are transforming health care through earlier disease detection, less invasive procedures and more effective treatments. AdvaMed members range from the largest to the smallest medical technology innovators and companies. For more information, visit